Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease

Obesity Research and Clinical Practice

Volumn 9, Issue 2, 2015, Pages 168-174

  Wanezaki, Satoshi ^a   Tachibana, Nobuhiko ^a   Nagata, Mayuko ^a   Saito, Shintaro ^b   Nagao, Koji ^b   Yanagita, Teruyoshi ^c   Kohno, Mitsutaka ^a  

^a FUJI OIL CO LTD   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c NISHIKYUSHU UNIVERSITY   (Japan)

Author keywords

Fatty acid synthase; NAFLD; OLETF; CG

Indexed keywords

BETA CONGLYCININ; CASEIN; CHOLESTEROL; FATTY ACID SYNTHASE; PHOSPHOLIPID; SOYBEAN EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BETA-CONGLYCININ PROTEIN, GLYCINE MAX; GLOBULIN; LIPID; PLANT ANTIGEN; PLANT EXTRACT; PROTEIN INTAKE; SEED STORAGE PROTEIN; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; DIETARY INTAKE; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; FOOD INTAKE; GENE EXPRESSION; LIVER WEIGHT; MALE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RAT; RAT MODEL; SOYBEAN; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE; ANIMAL; BLOOD; CHEMISTRY; COMPLICATION; DIET THERAPY; DRUG EFFECTS; GENETICS; LIPOGENESIS; LIVER; METABOLISM; ORGAN SIZE; PHARMACOLOGY; PROTEIN INTAKE; THERAPEUTIC USE;

RATTUS;

ANIMALS; ANTIGENS, PLANT; DIETARY PROTEINS; GENE EXPRESSION; GLOBULINS; LIPIDS; LIPOGENESIS; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ORGAN SIZE; PLANT EXTRACTS; RATS; RATS, INBRED OLETF; SEED STORAGE PROTEINS; SOYBEAN PROTEINS; SOYBEANS;

EID: 84927912416     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2014.03.005     Document Type: Article

References (24)

1. P.G. Kopelman Obesity as a medical problem Nature 404 2000 635 643 [review]
2. J.M. Friedman Obesity: causes and control of excess body fat Nature 459 2009 340 342
3. The World Health Organization Obesity and overweight. Fact sheet N° 311 2013 [updated March 2013]
4. T. Takamura, H. Misu, T. Ota, and S. Kaneko Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver Endocr J 59 2012 745 763
5. Y.K. Chen, C. Cheung, K.R. Reuhl, A.B. Liu, M.J. Lee, and Y.P. Lu Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice J Agric Food Chem 59 2011 11862 11871
6. Y.S. Seo, J.H. Kim, N.Y. Jo, K.M. Choi, S.H. Baik, and J.J. Park PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes J Gastroenterol Hepatol 23 2008 102 109
7. Y.M. Wang, K. Nagao, N. Inoue, Y. Ujino, Y. Shimada, and T. Nagao Isomer-specific anti-obese and hypolipidemic properties of conjugated linoleic acid in obese OLETF rats Biosci Biotechnol Biochem 70 2006 355 362
8. K. Nagao, N. Inoue, Y.M. Wang, J. Hirata, Y. Shimada, and T. Nagao The 10trans, 12cis isomer of conjugated linoleic acid suppresses the development of hypertension in Otsuka Long-Evans Tokushima fatty rats Biochem Biophys Res Commun 306 2003 134 138
9. N. Inoue, K. Nagao, K. Sakata, N. Yamano, P.E. Gunawardena, and S.Y. Han Screening of soy protein-derived hypotriglyceridemic di-peptides in vitro and in vivo Lipids Health Dis 10 2011 85
10. N. Inoue, K. Nagao, S. Nomura, B. Shirouchi, M. Inafuku, and H. Hirabaru Effect of Vaccinium ashei reade leaf extracts on lipid metabolism in obese OLETF rats Biosci Biotechnol Biochem 75 2011 2304 2308
11. K. Nagao, N. Yamano, B. Shirouchi, N. Inoue, S. Murakami, and T. Sasaki Effects of citrus auraptene (7-geranyloxycoumarin) on hepatic lipid metabolism in vitro and in vivo J Agric Food Chem 58 2010 9028 9032
12. K. Nagao, T. Jinnouchi, S. Kai, and T. Yanagita Effect of dietary resveratrol on the metabolic profile of nutrients in obese OLETF rats Lipids Health Dis 12 2013 8
13. T. Aoyama, M. Kohno, T. Saito, K. Fukui, K. Takamatsu, and T. Yamamoto Reduction by phytate-reduced soybean beta-conglycinin of plasma triglyceride level of young and adult rats Biosci Biotechnol Biochem 65 2001 1071 1075
14. N. Tachibana, Y. Iwaoka, M. Hirotsuka, F. Horio, and M. Kohno Beta-conglycinin lowers very-low-density lipoprotein-triglyceride levels by increasing adiponectin and insulin sensitivity in rats Biosci Biotechnol Biochem 74 2010 1250 1255
15. M. Kohno, M. Hirotsuka, M. Kito, and Y. Matsuzawa Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean beta-conglycinin J Atheroscler Thromb 13 2006 247 255
16. T. Moriyama, K. Kishimoto, K. Nagai, R. Urade, T. Ogawa, and S. Utumi Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption Biosci Biotechnol Biochem 68 2004 352 359
17. T. Yamazaki, K. Kishimoto, S. Miura, and O. Ezaki Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein J Nutr Biochem 23 2012 123 132
18. I. Ikeda, R. Konno, T. Shimizu, T. Ide, N. Takahashi, and T. Kawada Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARα, promotes energy consumption and reduces visceral fat deposition in rats Biochim Biophys Acta 1760 2006 800 807
19. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
20. S.J. Wakil, and L.A. Abu-Elheiga Fatty acid metabolism: target for metabolic syndrome J Lipid Res 50 2009 S138 S143
21. M. Nakamuta, M. Kohjima, S. Morizono, K. Kotoh, T. Yoshimoto, and I. Miyagi Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease Int J Mol Med 16 2005 631 635
22. Y. Homma Predictors of atherosclerosis J Atheroscler Thromb 11 2004 265 270
23. R.F. Mortensen C-reactive protein, inflammation, and innate immunity Immunol Res 24 2 2001 163 176
24. A. Kotronen, and H. Yki-Järvinen Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 2008 27 38